Heidelberg Pharma AG

Director's Dealing • Aug 23, 2022

News Details

Directors’ Dealings | 23 August 2022 21:00

DGAP-DD: Heidelberg Pharma AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

23.08.2022 / 21:00

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form:	4H invest GmbH

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Prof.
First name:	Christof
Last name(s):	Hettich
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Derivative
ISIN:	DE000A2888P1

b) Nature of the transaction

Transfer of 850,517 subscription rights to Huadong Medicine Investment Holdinq (Honqkonq) Limited.

c) Price(s) and volume(s)

Price(s)	Volume(s)
0.00 EUR	0.00 EUR

d) Aggregated information

Price	Aggregated volume
0.00 EUR	0.00 EUR

e) Date of the transaction

2022-08-18; UTC+2

f) Place of the transaction

Outside a trading venue

---

23.08.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	Heidelberg Pharma AG
	Gregor-Mendel-Str. 22
	68526 Ladenburg
	Germany
Internet:	www.heidelberg-pharma.com

End of News	DGAP News Service